Abstract:Next-generation sequencing has made possible the detection of rare variant (RV) associations with quantitative traits (QT). Due to high sequencing cost, many studies can only sequence a modest number of selected samples with extreme QT. Therefore association testing in individual studies can be underpowered. Besides the primary trait, many clinically important secondary traits are often measured. It is highly beneficial if multiple studies can be jointly analyzed for detecting associations with commonly measured traits. However, analyzing secondary traits in selected samples can be biased if sample ascertainment is not properly modeled. Some methods exist for analyzing secondary traits in selected samples, where some burden tests can be implemented. However p-values can only be evaluated analytically via asymptotic approximations, which may not be accurate. Additionally, potentially more powerful sequence kernel association tests, variable selection-based methods, and burden tests that require permutations cannot be incorporated. To overcome these limitations, we developed a unified method for analyzing secondary trait associations with RVs (STAR) in selected samples, incorporating all RV tests. Statistical significance can be evaluated either through permutations or analytically. STAR makes it possible to apply more powerful RV tests to analyze secondary trait associations. It also enables jointly analyzing multiple cohorts ascertained under different study designs, which greatly boosts power. The performance of STAR and commonly used RV association tests were comprehensively evaluated using simulation studies. STAR was also implemented to analyze a dataset from the SardiNIA project where samples with extreme low-density lipoprotein levels were sequenced. A significant association between LDLR and systolic blood pressure was identified, which is supported by pharmacogenetic studies. In summary, for sequencing studies, STAR is an important tool for detecting secondary-trait RV associations.

A method to estimate the contribution of rare coding variants to complex trait heritability

Estimating Genetic Effects and Quantifying Missing Heritability Explained by Identified Rare-Variant Associations

A Probabilistic Method for Identifying Rare Variants Underlying Complex Traits

RAVAR: a curated repository for rare variant–trait associations

Approach of Fusing Multiple Tests to Analyzing Rare Genetic Variants

Integration of variant annotations using deep set networks boosts rare variant association testing

Identifying rare variants using a Bayesian regression approach

RVTESTS: an Efficient and Comprehensive Tool for Rare Variant Association Analysis Using Sequence Data.

Probabilistic inference of the genetic architecture underlying functional enrichment of complex traits

Rare variant effect estimation and polygenic risk prediction

Polygenic architecture of rare coding variation across 394,783 exomes

Rare variant contribution to the heritability of coronary artery disease

Contribution of rare variants to heritability of a disease is much greater than conventionally estimated: modification of allele distribution model

Functional gene embeddings improve rare variant polygenic risk scores

A Method to Estimate the Contribution of Regional Genetic Associations to Complex Traits from Summary Association Statistics

Inferring disease risk genes from sequencing data in multiplex pedigrees through sharing of rare variants

Rare variant contribution to human disease in 281,104 UK Biobank exomes

A unified method for detecting secondary trait associations with rare variants: application to sequence data.

A Robust and Powerful Set-Valued Approach to Rare Variant Association Analyses of Secondary Traits in Case-Control Sequencing Studies.

Simultaneous Analysis of Common and Rare Variants in Complex Traits: Application to SNPs (Scarvasnp)

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores